01/12/2021 12:27
Clarín.com
Society
Updated 01/12/2021 12:27 PM
The number of vaccinated people who suffered adverse effects after applying the first dose of the
Sputnik V
vaccine
in Argentina
increased in percentage from 2.7% to 3.85%
.
This follows from the third report that the Ministry of Health and the National Commission for Vaccine Safety released this Tuesday.
The report is based on the notifications of 3,453 ESAVI (Event supposedly attributed to vaccines and immunizations) registered in the SIISA (Integrated Argentine Health Information System) between December 29 when the vaccination began and January 8,
when they had been applied 89,576 doses
reported according to the Federal Register of Nominal Vaccination (NoMiVac).
There it is also clarified that
99.3% of the adverse effects
reported after the application of the first dose of Sputnik V were "mild and moderate".
The detail of these 3,453 notifications indicates that 32.4% correspond to people with fever, headache and / or myalgia within 24 hours;
52.74% reported headache and / or myalgia without fever;
7.10% only fever;
1.53% local reaction to injection;
1.62%, mild allergy and 1.36% gastrointestinal symptoms.
Only 25 patients were hospitalized
for symptomatic treatment and all recovered, according to the Directorate of Control of Immunopreventable Diseases of the Ministry of Health.
In previous reports, no hospitalizations had been recorded.
In the second safety report on the Sputnik V vaccine, 1,088 cases of mild and moderate adverse effects had been reported after the first 39,599 doses applied.
A doctor receives the vaccine in a hospital in Berisso.
Photo: Mauricio Nievas.
Among the expected reactions after receiving the Sputnik V vaccine, pain at the injection site, hyperemia, and swelling may occur.
Also systemic reactions: short-lived flu-like syndrome with onset within 24 to 48 hours (characterized by chills, fever, arthralgia, myalgia, asthenia, malaise, headache) or less frequent gastrointestinal symptoms (nausea, dyspepsia, decreased appetite) .
These reactions last an average of 24 hours.
The third report also notes that
23 of the 24 jurisdictions reported such events
attributable to vaccines and reminds vaccinated people to consult the nearest health center if post-vaccination symptoms appear.
"Although vaccination is contraindicated for the moment in breastfeeding women, its administration is not a reason to suspend it," he adds.
In addition, the report indicates to those who had mild to moderate effects that "they
must complete the vaccination schedule
with a minimum interval of 21 days
, because the data from Phase 1-21 showed a lower frequency of AE (adverse effects) when administering the second dose (Adv5 component) ".
The Ministry of Health also reminds health workers that any symptoms must be notified to the SIISA within the first 24 hours in cases of severe ESAVI, and within the first week in the rest of the events. not serious.
With information from Télam.
JPE
Look also
Coronavirus: Equine serum proved effective in treating patients
Russian vaccine against coronavirus: the second shipment of Sputnik V would arrive between January 15 and 20 to Argentina